Effect Of Euphorbia Cyparissias Ointments On Acanthosis by Cristina, RT et al.
Cristina et al., Afr J Tradit Complement Altern Med. (2014) 11(3):1-6
http://dx.doi.org/10.4314/ajtcam.v11i3.1
1
EFFECT OF EUPHORBIA CYPARISSIAS OINTMENTS ON ACANTHOSIS
Romeo T. Cristina1*, Eugenia Dumitrescu1, Diana Brezovan2, Florin Muselin3
Viorica Chiurciu4
1Pharmacology and Pharmacy Dept., USAMVB, Faculty of Veterinary Medicine, 119, Calea Aradului, Timișoara, 
Romania. 2Histology and Molecular biology Dept., USAMVB, Faculty of Veterinary Medicine, 119, Calea Aradului,
Timișoara, Romania. 3Botany Dept., USAMVB, Faculty of Veterinary Medicine, 119, Calea Aradului, Timișoara, 
Romania. 4Drugs Production Dept., Romvac Company, Şos. Centurii no. 7, Voluntari, Romania.
*Email: rtcristina@yahoo.com
Abstract
Background: A pharmaco-chemical investigation of the Euphorbia cyparissias plant was justified by its known multiple therapeutic valences.
Numerous components from extracts and latex of Euphorbiacae were identified, revealing a large plant family with a polyvalent therapeutic
activity.
Materials and Methods: The aim of the study was to assess the skin tolerance level to irritation on different testing concentrations, of Euphorbia
cyparissias extracts and ointments. Study was accomplished in rats and dogs, with the identification of all possible skin injuries and histological
changes, after a simple patch test methodology.
Results: Ointment dermatological testing on rats, proved to be bearable on epilated skin at concentrations of 1, 2 and 5%. Ointments and mother
tincture with higher concentrations (10% and 20%), led to irritation and cutis damages, and this was revealed through histology.
Conclusion: Ointment tested on dog’s skin was tolerable for epilated skin to concentrations of 1, 2 and/or 5%, additional testing on human
volunteers confirmed the same situation.
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Introduction
In modern human and veterinary therapeutics, the concept of biotherapy has become more frequent. In this context, researchers from all
over the world are seeking to align, and to bring new information in relation to the use of plants from the spontaneous flora as well as other
modern means in the anti-parasitic arsenal (Madzimure et al., 2011; Sanis et al., 2012; Samish and Rehacek, 1999; Santhoshkumar et al., 2012;
Webb and David, 2002). The preoccupations linked to the parasites’ control and bio-control models (Barci, 1997; Jongejan and Uilenberg, 1994;
Kaaya, 2003), have diversified, numerous new fight means like: fungus (Kaaya, 1996), entomogenous nematodes (Kaaya et al., 2000; Samish and
Glazer, 1991), vegetal extracts (Borges et al., 2003; De Souza Chagas et al., 2012; Schwalbach et al., 2003), volatile oils (Iori et al., 2005;
Ismail et al., 2002; Kim et al., 2004; Walton et al., 2004) and other, being studied.
Numerous components from extracts and latex of Euphorbiacee were identified, mostly diterpenes: phorbolester (ingenole), euphorbone,
piceatanole, aesculetine, jolkinol, hyperoside, kaempferol, acylphorbol, acylingenol etc. (Ahmad and Jassbi, 1999; Evanics et al., 2001; Ferriera et
al., 1993). Pharmaco-chemical investigation of the Euphorbiaceae family is justified by its known multiple therapeutic valences (Özbilgin and
Saltan Citoğlu, 2012; Tabuti, 2008). Numbering over 3000, species, this large plant family is a polyvalent one from a medicinal point of view:
with cancer studied efficiency (Wang et al., 2012), homeopathic (Garcia et al., 2010), anti-inflammatory (Singh et al., 1984), insecticidal (Zahir
and Rahuman, 2012), repellent (Ogunlesi et al., 2009), antiviral (Akihisa et al., 2002), diuretic (Ashok et al., 2011) and many others (Shih and
Cherng, 2012).
The aim was to assess the skin tolerance to irritation on different testing concentrations, of Euphorbia cyparissias extracts and ointments,
in laboratory rats and dog, with the identification of all possible skin injuries and histological changes, registering, after a simple patch test
methodology, as a preliminary step in conception of a final formulation, a specific ointment with E. cyparissias extract.
Materials and Methods
Euphorbia ointment and dilutions preparation
Euphorbia cyparissias was collected from Banat region, Western Romania (plant’s identification and authentication was made; plant
being compared with a herbarium specimen (voucher no. 41), from the collection of Vegetal Biology and Medicinal Plants Department from
FVM Timisoara, Romania.
Plant extracts were obtained according to Romanian Pharmacopeia, Xth Ed. (1993), instructions at Tincturae or Unguenta monographs.
100 ml E. cyparissias, 20% mother tincture previously obtained was evaporated and concentrated on marine bath. Over it, 50 g ointment base was
added progressively, mixing continuously for 20 minutes, until total tincture’s embedding in the ointment mass. After homogenisation the hot
ointment was poured in plastic boxes, eliminating oxygen bubbles and left to stand for 60 minutes, so being obtained a prime 10% E. cyparissias
ointment.
The used ointment base, Ultrabasic cream (Ratiopharm GmbH, Germany), was an amphiphylic complex basis adjusted to pH = 5,
choosing of this ointment base being precisely recommended, due to its good incorporating features of the vegetal complex compositions, tannins,
latex, oils etc. For this reason, this base was considered ideal for skin topical applications, being well tolerated and forming uniform films on skin.
Hot 10% ointment was then successively diluted in the following proportions: 1:1 (w/w) to obtain concentration of 5%; 1: 2.5 (w/w) to a
concentration of 2% and respectively; 1:1 (w/w) to concentration of 1%.
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As initial testing before the patch test, the mother E. cyparissias tincture 20% concentration (considered by us as the maximum
therapeutic concentration in animals) it was used only on rats, in the aim to see if there are any changes that may occur in cutis structure,
Application of the E. cyparissias ointments was accomplished with protected hand, avoiding the contact with eyelid mucous.
Patch-test methodology
The test was performed accordingly to a simple patch test method protocols, accepted in dermatology, both for rats and dog. During
testing, all major local and general side effects: the degree and nature of irritation, mother tincture and ointment’s corrosivity, reversibility of
installed damages and any other local or general toxic effect (Ale and Maibach, 2010; DermNet NZ, 2012; Spiewak, 2008). In Table 1, animals
used and methodology are presented.
Table 1: Animals’ used and simple patch-test methodology
Rats 12; clinically healthy animals, three / concentration.
Dog Clinically healthy animal, the ointment concentrations were
applied consequently on abdominal region in different
epilated areas.
Human volunteer
Testing was meant to indicate any general or secondary
effects that could appear in humans after the unprotected
ointment applying to animals, in accidental touch of the eye
region.
Consequently 1, 2, and 5% ointments were applied on the
arm and lid. In the case of palbebral topical applications,
ointments were applied on eyelids as follows: right upper
eyelid 1%, lower left eyelid 2% above 5%.
Control lot Not necessary
Preliminary test Ointment’s pH values assessment (not allowed if the
substance has a pH ≤ 2 or ≥ 11.5) 
Skin preparing Hair removal 24 hours before testing without skin lesions,
followed by light scarification
Application area 4 cm2 (2/2 cm)
Dressing Gauze bandage soaked in ointment and fixed with adhesive
bandage
Exposure time 30 minutes
Number of applications One
Skin reaction monitoring after application at 30 min., 8, 24, 36 and 48 h
Skin reaction assessing was done after classical scoring by grades from 0 to 4, final quantification of sensitivity testing being based on average
mark of the subjects included in the study (Table 2).
Table 2: Evaluation of skin reaction after skin applications
Classification of reactions identified consecutive exposures Cathegory Average
no visible reaction, possibly slight desquamation




congestion and inflammation which decreases in 36 hours Average
affordability
1.0 – 2.79
congestion and inflammation which not decreases in 36 hours Irritant 2.80 – 3.69
congestion and pustules lymph extravasations, prolonged healing time of 48
hours
Severe irritant 3.70 – 4.0
Histological investigation
Skin samples
Samples were collected from rats euthanized in the respect of current standards of ethics in scientific research. Rats were euthanized in
accordance with European Directive 2010/63/EU from 09/22/2010. Euthanasia method used was that by overdosing anesthetic agents using the
association: Ketamine (Intervet, Boxmeere, The Netherlands) (300 mgkg-1bw) and xylazine Narcoxyl 2 (Xylazine, MSD Animal Health,
Boxmeere, The Netherlands) 30 mgkg-1bw, i.e. 0.3 ml ketamine + 0.15 ml xylazine /100gkg-1bw, by I.P. or S.C. way, in accordance with existing
own institutional bioethical and all performed procedures (CETS No.: 123, 1986; Directive 2010/63/EU; SVH AEC SOP.26, 2006).
Skin flaps from rats were placed in 5% formalin solution for histological processing (Șincai, 2000). From dog the skin samples were 
collected surgically and places were sanitized and coated with protective sulphonamide powder, to avoid any local infections.
Staining method
The method used for rat skin was haematoxylin-eosin (col. H & E). For coloration of dog skin samples, trichromic Mallory staining was
used (col. TRC), which contains acid fuchsine solution, phosphomolybdate acid solution and Mallory mix, being a specific staining for
conjunctive tissue, nuclei and fibres (Șincai, 2000), microscopy being performed to the Olympus CX 41(Olympus, GmbH Germany), equipped
with a camera, to the objective x 200 (H&E), and of x 400 (col. TRC).




Tested ointment proved to be bearable on rats’ epilated skin at concentrations of 1, 2, and / or 5% (Table 3). Contact of rats skin with high
concentrations ointment (10%), led to reduced and short term irritation of the cutis and caused reactions includable in skin tolerance Class I =
medium irritating. When mother tincture (20%) was used, detected changes were characteristic to category SI = strong irritant reactions, due to
irritating action, situation also revealed by the histological examination (Figures 1 to 6).







20% 3 3 Irritant
10% 3 1 Average affordability
5% 3 0,66 Supportable irritant
2% 3 0,33 Supportable non-irritant
Histological
To concentrations inferior to 20%, were not identified significant histological changes. The main changes identified were: thickening of
the epidermis, especially of the stratum corneum, keratinocytes vacuolar degeneration, small areas damage of lamina basalis, who separates the
epidermis and papillary dermis and occurrence of cells specific to dermal inflammatory process (only at concentrations of 10% and especially to
20%) (Figures 1 to 6).
Figure 1: Histologic examination of the skin treated with E. cyparissias 1% ointment (col. H&E x 200). (all color figures have resolution of 300
dpi).
Histological sections revealed that the epidermis has a normal appearance with multi-layered intact epithelium, where there are
vacuolated keratinocytes but in reduced proportion (red). Skin thickness is maintained within normal limits. In the dermis were revealed very few
inflammatory cells (orange). Also glandular structures (in particular, the sebaceous gland (blue) corneous formations (hair) do not show
significant changes.
Figure 2: Histologic examination of the skin treated with the ointment of E. cyparissias at a concentration of 2% (Col. H&E x 200).
Histologic examination of the skin did not highlighted major changes. Epidermis showed no structural changes or of thickness but compared with
group 1% it was found an increased number of inflammatory type cells (red).
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Figure 3. (Col. H&E x 200) Figure 4. (Col. H&E. x 200)
Figure 3 and Figure 4. Histologic examination of the skin that was applied with 5 (fig. 3) and 10% (fig. 4) ointment concentrations (Col. H&E x
200).
Histologic examination of the skin that was applied with 5 (fig. 3) and 10% (fig. 4) ointment concentrations (col. H&E x 200)
Histologic examination of the skin showed for both concentrations, but especially for the higher one, development of the contact
dermatitis phenomena. Diskeratosis, hypo- or parakeratosis (orange) it was observed also altered membrana basalis and circumscribed cellular
infiltrations in dermis were observed, as the occurrence of specific inflammatory process (red).
?
Figure 5. (Col. H&E x 200) Figure 6. (Col. H&E x 200)
Histologic examination of the skin treated with E. cyparissias mother tincture (20%)
Figure 5 and Figure 6. Histologic examination of the skin treated with E. cyparissias mother tincture (20%)
Histologic examination of the skin showed worsening of contact dermatitis. In addition, most of the sebaceous glands necrosis in
various stages from partial (red) to complete (black) of secretor and basal proliferative cells, which become flattened. Alveolar sacs are empty of
cells and by its secretion product. These aspects indicate severe reduction in functional capacity of the sebaceous gland (fig.5). Thus, the sebum
quantity secreted are greatly diminished, a phenomenon that explains the dry and brittle skin in case of concentrated ointments using. In the
dermis massive cellular infiltration was observed, specific to inflammatory processes (red) (Figure.6).
Dermatological testing in dog
Evaluation of coetaneous tolerance for ointments was followed on a Cocker spaniel dog. Testing showed total non-irritant character of
1%, 2% ointment concentrations, not being identified any local or general reactions. In the case of 5% concentration, only light coetaneous
reactions, reported tolerance values being includable in B = bearable category of acanthosis.
Histological
The main histological changes were observed in skin structure only after applying E. cyparissias ointment with concentration of 5% and
there were: thickening of the epidermis, especially of stratum corneum, keratinocytes’ vacuolar degeneration, destruction of small portions of
lamina basalis, specific for the dermal inflammatory process (for 5% ointment). It is to note that at lower concentrations weren’t identified any
significant histological changes (Figures 7 and 8).
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Figure 7. (Col. TRC x 400) Figure 8. (Col. TRC x 400)
Figsures 7 and 8: Sections made through the dog’s skin consecutive applications of 5% E cyparissias ointment concentration (Col. TRC x 400)
Section made through the dog’s skin consecutive applications of 5% E cyparissias ointment concentration (col. TRC x 400)
Thickening of epidermis (orange); skin peeling (black); vacuolar degeneration of keratinocytes (blue); destruction of lamina basalis (red); cell
proliferation in the dermis, specific to inflammatory process (green).
Dermatologic observations on human volunteer
Applications on arm’ skin did not cause any irritation, discoloration or volume modification at any of the studied concentrations. In the
case of palbebral topical applications, ointments were applied on eyelids as follows: right upper eyelid 1%, lower left eyelid 2% above 5%. After
3-8 hours after ointments application, subject felt a diffuse burning irritation only after applying ointment with concentration of 5%. Irritation was
felt only to the correspondent lid (top left). After 8 hours after application, sore diminished, but the complete recovery after swelling of the eyelids
was observed only at 24 hours after application. Edema was persistent yet after 48 hours of application, but it was not accompanied by pain or
other event. Accordingly to our estimation methodology, recorded effects can be included in average affordability (1 to 2.79).
Studies made by our research team about the active compounds of Euphorbia cyparissias (Cypress spurge) as well as their activity in vivo
and in vitro revealed additional significant ectoparasitic activity, especially against argasides and dog’s demodectic mange (Cristina et al., 2008).
Present testing occurred due to the need to further studies of the above-mentioned compounds activity in demodicosis, a zoonotic skin parasitic
disease frequent in dogs and enough spread in humans, where the ointment was originally used by us and where acanthosis studies are needed
(Lachapelle and Maibach, 2012, EAHC, 2009; Spiewak, 2008).
Conclusions
Euphorbia cyparissias ointment dermatologically tested on rats, proved to be bearable on epilated skin at concentrations of 1, 2 and 5%.
Ointments and mother tincture with higher concentrations (10% and 20%) led to irritation and cutis damages, histologicaly revealed. Ointment
tested on dog’s cutis appears to be tolerable for epilated skin to concentrations of 1, 2 and/or 5%. However, to the contact with epilated skin of
ointments with concentration of 5%, can register very small and short term irritation of the cutis, which can be considered therapeutically
negligible, histological examination revealing this situation. Euphorbia cyparissias ointment can be used in veterinary therapy at the
concentrations of 2 and 5% without encountering difficulty, ointments at this concentration being included in the bearable non-irritant category.
Application of E. cyparissias ointments hould be made with protected hand, avoiding the contact with mucous eyelid.
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